Íæż½ã½ã

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last 7 days
Scrip Pharma Intelligence12:34 18-Sep-24
BioNTech (Press Release)06:46 17-Sep-24
The Motley Fool04:33 17-Sep-24
BioPharma Dive12:18 16-Sep-24
ENDPOINTS11:51 16-Sep-24
Benzinga10:43 13-Sep-24
In the last month
pharmaphorum06:11 12-Sep-24
PR Newswire (Press Release)18:13 11-Sep-24
Benzinga12:19 11-Sep-24
Seeking Alpha07:29 11-Sep-24
FierceBiotech05:44 11-Sep-24
Benzinga14:11 6-Sep-24
Forbes05:58 6-Sep-24
BioNTech (Press Release)07:19 5-Sep-24
GlobeNewswire (Press Release)09:48 4-Sep-24
Business Wire (Press Release)08:33 4-Sep-24
JD Supra14:49 3-Sep-24
Skeptical Raptor17:37 2-Sep-24
UPI20:14 31-Aug-24
Benzinga12:09 29-Aug-24
JD Supra13:54 28-Aug-24
ENDPOINTS11:53 27-Aug-24
FierceBiotech09:33 27-Aug-24
Clinical Trials Arena06:39 26-Aug-24
GlobeNewswire (Press Release)13:33 25-Aug-24
Seeking Alpha14:27 23-Aug-24
FiercePharma11:26 23-Aug-24
IFLScience11:08 23-Aug-24
RTT News08:22 23-Aug-24
PMLiVE07:31 23-Aug-24
pharmaphorum04:34 23-Aug-24
TipRanks16:59 22-Aug-24
Benzinga14:40 22-Aug-24
GlobeNewswire (Press Release)14:19 22-Aug-24
Seeking Alpha17:26 20-Aug-24
Biopharma Reporter11:40 20-Aug-24
Scrip Pharma Intelligence11:39 20-Aug-24
Clinical Trials Arena06:25 20-Aug-24
view more headlines
18 Sep 12:34

About our BioNTech news

Latest news on BioNTech, a German biotechnology company that makes active immunotherapies for patient-specific approaches to the treatment of diseases.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.